Abstract
Confirming the in vivo efficacy of potential antileishmanial compounds that display in vitro potency and good chemical characteristics is one of the most important steps in preclinical research drug discovery before human clinical trials begin. Here we describe the use of the in vivo bioluminescent monitoring of high and low inocula of luciferase-expressing Leishmania major (L. major) parasites in traditional and more innovative rodent models of in vivo cutaneous leishmaniasis (CL) drug discovery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
World Health Organization (2010) Control of the leishmaniases. World Health Organ Tech Rep Ser 949:xii–xiii 1-186
Croft SL, Seifert K, Yardley V (2006) Current scenario of drug development for leishmaniasis. Indian J Med Res 123(3):399–410
Pigott DM, Bhatt S, Golding N et al (2014) Global distribution maps of the leishmaniases. Elife 3. https://doi.org/10.7554/eLife.02851
Mears ER, Modabber F, Don R, Johnson GE (2015) A review: the current in vivo models for the discovery and utility of new anti-leishmanial drugs targeting cutaneous leishmaniasis. PLoS Negl Trop Dis 9(9):e0003889. https://doi.org/10.1371/journal.pntd.0003889
Robledo SM, Carrillo LM, Daza A et al (2012) Cutaneous leishmaniasis in the dorsal skin of hamsters: a useful model for the screening of antileishmanial drugs. J Vis Exp 62:3533. https://doi.org/10.3791/3533
Milon G, Del Giudice G, Louis JA (1995) Immunobiology of experimental cutaneous leishmaniasis. Parasitol Today 11(7):244–247
Gomes-Silva A, Valverde JG, Ribeiro-Romao RP et al (2013) Golden hamster (Mesocricetus auratus) as an experimental model for Leishmania (Viannia) braziliensis infection. Parasitology 140(6):771–779. https://doi.org/10.1017/S0031182012002156
Ribeiro-Romao RP, Moreira OC, Osorio EY et al (2014) Comparative evaluation of lesion development, tissue damage, and cytokine expression in golden hamsters (Mesocricetus auratus) infected by inocula with different Leishmania (Viannia) braziliensis concentrations. Infect Immun 82(12):5203–5213. https://doi.org/10.1128/IAI.02083-14
Kimblin N, Peters N, Debrabant A et al (2008) Quantification of the infectious dose of Leishmania major transmitted to the skin by single sand flies. Proc Natl Acad Sci U S A 105(29):10125–10130. https://doi.org/10.1073/pnas.0802331105
Abdeladhim M, Kamhawi S, Valenzuela JG (2014) What’s behind a sand fly bite? The profound effect of sand fly saliva on host hemostasis, inflammation and immunity. Infect Genet Evol 28:691–703. https://doi.org/10.1016/j.meegid.2014.07.028
Belkaid Y, Kamhawi S, Modi G et al (1998) Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis. J Exp Med 188(10):1941–1953
Cawlfield A, Vesely B, Ngundam F et al (2018) Use of in vivo imaging system technology in Leishmania major BALB/c mouse ear infection studies. J Med Entomol 55(2):429–435. https://doi.org/10.1093/jme/tjx219
Greer LF 3rd, Szalay AA (2002) Imaging of light emission from the expression of luciferases in living cells and organisms: a review. Luminescence 17(1):43–74. https://doi.org/10.1002/bio.676
Lang T, Goyard S, Lebastard M, Milon G (2005) Bioluminescent Leishmania expressing luciferase for rapid and high throughput screening of drugs acting on amastigote-harbouring macrophages and for quantitative real-time monitoring of parasitism features in living mice. Cell Microbiol 7(3):383–392. https://doi.org/10.1111/j.1462-5822.2004.00468
Roy G, Dumas C, Sereno D et al (2000) Episomal and stable expression of the luciferase reporter gene for quantifying Leishmania spp. infections in macrophages and in animal models. Mol Biochem Parasitol 110(2):195–206
Thalhofer CJ, Graff JW, Love-Homan L et al (2010) In vivo imaging of transgenic Leishmania parasites in a live host. J Vis Exp 41:1980. https://doi.org/10.3791/1980
Caridha D, Parriot S, Hudson TH et al (2017) Use of optical imaging technology in the validation of a new, rapid, cost-effective drug screen as part of a tiered in vivo screening paradigm for development of drugs to treat cutaneous leishmaniasis. Antimicrob Agents Chemother 61(4):e02048-16. https://doi.org/10.1128/AAC.02048-16
Schuster S, Hartley MA, Tacchini-Cottier F, Ronet C (2014) A scoring method to standardize lesion monitoring following intra-dermal infection of Leishmania parasites in the murine ear. Front Cell Infect Microbiol 4:67. https://doi.org/10.3389/fcimb.2014.00067
Lecoeur H, Buffet PA, Milon G, Lang T (2010) Early curative applications of the aminoglycoside WR279396 on an experimental Leishmania major-loaded cutaneous site do not impair the acquisition of immunity. Antimicrob Agents Chemother 54(3):984–990. https://doi.org/10.1128/AAC.01310-09
Lecoeur H, Buffet P, Morizot G et al (2007) Optimization of topical therapy for Leishmania major localized cutaneous leishmaniasis using a reliable C57BL/6 model. PLoS Negl Trop Dis 1(2):e34. https://doi.org/10.1371/journal.pntd.0000034
Sacks DL, Melby PC (2001) Animal models for the analysis of immune response to leishmaniasis. Curr Protoc Immunol . Chapter 19: Unit 19.2. https://doi.org/10.1002/0471142735.im1902s28
Sacks DL, Melby PC (2015) Animal models for the analysis of immune response to leishmaniasis. Curr Protoc Immunol 108(19):2): 1–2):24. https://doi.org/10.1002/0471142735.im1902s28
Fischer MR, Dominik J, Kautz-Neu K et al (2013) Animal model for cutaneous leishmaniasis. In: Has C, Sitaru C (eds) Molecular dermatology. Methods in molecular biology (methods and protocols), vol 961. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-227-8_26
Lawyer P, Killick-Kendrick M, Rowland T et al (2017) Laboratory colonization and mass rearing of phlebotomine sand flies (Diptera, Psychodidae). Parasite 24:42. https://doi.org/10.1051/parasite/2017041
Baldwin TM, Elso C, Curtis J et al (2003) The site of Leishmania major infection determines disease severity and immune responses. Infect Immun 71(12):6830–6834. https://doi.org/10.1128/IAI.71.12.6830-6834.2003
Spath GF, Beverley SM (2001) A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation. Exp Parasitol 99(2):97–103
Turner PV, Brabb T, Pekow C, Vasbinder MA (2011) Administration of substance to laboratory animals: routes of administration and factors to consider. J Am Assoc Lab Anim Sci 50(5):600–613
Nasseri M, Modabber FZ (1979) Generalized infection and lack of delayed hypersensitivity in BALB/c mice infected with Leishmania tropica major. Infect Immun 26(2):611–614
Acknowledgments
Disclaimer: Material has been reviewed by the Walter Reed Army Institute of Research. There is no objection to its presentation and/or publication. The opinions or assertions contained herein are the private views of the author, and are not to be construed as official, or as reflecting true views of the Department of the Army or the Department of Defense.
Research was conducted under an approved animal use protocol in an AAALACi accredited facility in compliance with the Animal Welfare Act and other federal statutes and regulations relating to animals and experiments involving animals and adheres to principles stated in the Guide for the Care and Use of Laboratory Animals, NRC Publication, 2011 edition.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Caridha, D., Leed, S., Cawlfield, A. (2020). In Vivo Bioluminescent Monitoring of Parasites in BALB/c Mouse Models of Cutaneous Leishmaniasis Drug Discovery. In: Ripp, S. (eds) Bioluminescent Imaging. Methods in Molecular Biology, vol 2081. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9940-8_7
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9940-8_7
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9939-2
Online ISBN: 978-1-4939-9940-8
eBook Packages: Springer Protocols